PIK3CA and neoplasm: Nevertheless, it remains uncertain whether these patients have an insufficient adaptive immune response or, more likely, alterations within HNSCC with HPV integration (such as TRAF3 and PIK3CA mutations) facilitate the evasion of tumour cells from the immune system.